Page last updated: 2024-10-31

metoclopramide and Osteosarcoma

metoclopramide has been researched along with Osteosarcoma in 1 studies

Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.

Osteosarcoma: A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed)

Research Excerpts

ExcerptRelevanceReference
"In children and adolescents with osteosarcoma, granisetron was safe and more efficient than metoclopramide plus dimenhydrinate for controlling chemotherapy-induced emesis and nausea."5.12Contribution to the treatment of nausea and emesis induced by chemotherapy in children and adolescents with osteosarcoma. ( Caran, EM; Luisi, FA; Petrilli, AS; Tanaka, C, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Luisi, FA1
Petrilli, AS1
Tanaka, C1
Caran, EM1

Trials

1 trial available for metoclopramide and Osteosarcoma

ArticleYear
Contribution to the treatment of nausea and emesis induced by chemotherapy in children and adolescents with osteosarcoma.
    Sao Paulo medical journal = Revista paulista de medicina, 2006, Mar-02, Volume: 124, Issue:2

    Topics: Adolescent; Antiemetics; Antineoplastic Agents; Bone Neoplasms; Child; Dimenhydrinate; Female; Grani

2006